Navigation Links
QIAGEN N.V. (Nasdaq: QGEN) Invites You to Join Its Third Quarter 2007 Earnings Conference Call on the Web
Date:10/30/2007

VENLO, The Netherlands, Oct. 30 /PRNewswire-FirstCall/ -- In conjunction with QIAGEN's Third Quarter 2007 Earnings release, you are invited to listen to its conference call which will be broadcast live over the Internet on Tuesday, November 6, 2007 at 9:30 a.m. EST, with Peer M. Schatz, President and Chief Executive Officer and Roland Sackers, Chief Financial Officer.

What: QIAGEN N.V. -- Third Quarter 2007 Earnings Announcement

When: Tuesday, November 6, 2007 at 9:30 a.m. EST

Where: http://www.QIAGEN.com/goto/061107

How: Live over the Internet -- Simply log on to the Web at the

address above.

The corresponding presentation slides are available to download

in the investor relations section of QIAGEN's website at:

http://www.QIAGEN.com/goto/061107

Contact: Andreas Marathovouniotis, Russo Partners, 212-845-4253

QIAGEN N.V., a Netherlands holding company, is a leading provider of innovative technologies and products for pre-analytical sample preparation and molecular diagnostics solutions. QIAGEN has developed a comprehensive portfolio of more than 500 proprietary, consumable products and automated solutions for sample collection, and nucleic acid and protein handling, separation, and purification. QIAGEN also supplies diagnostic kits, tests, and assays for human and veterinary molecular diagnostics. The company's products are sold to academic research markets, and to leading pharmaceutical and biotechnology companies; as well as to diagnostics laboratories. QIAGEN also provides purification and testing solutions to applied testing markets: such as forensics, animal or food testing, and pharmaceutical process control.

QIAGEN employs more than 2,600 people worldwide. QIAGEN products are sold through a dedicated sale
'/>"/>

SOURCE QIAGEN N.V.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
2. Neurologix to Present at the Third Annual C.E. Unterberg Towbin Emerging Growth Conference
3. Lipitor Reduced the Risk of Coronary Events by Half and Stroke by Nearly One-Third in High-Risk Patients with Type 2 Diabetes Who Experienced a Recent Stroke
4. Can-Fite Proceeds with Development of Third Drug; Progress in Development of CF502 Will Be Presented at the Annual European Congress of Rheumatology
5. One-Third of Patients Discontinue Common Breast Cancer Therapy
6. CeNeRx BioPharma Announces Positive Phase I Results in First Human Trial of Third Generation RIMA Antidepressant
7. Phosphagenics to Commence Phase 1b Transdermal Insulin Clinical Trial in Second Quarter
8. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
9. ViaCell to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Accelrys to Present to Investors at C.E. Unterberg Emerging Growth Opportunities Conference
11. Metabasis to Present at C.E. Unterberg, Towbin Emerging Growth Conference and Attend Pacific Growth Equities Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...,, BEIJING,Nov.24/PRNewswire-Asia-FirstCall/-...("Lotus"orthe"Company")agrowingdeveloperand,produc...harmaceutical,productsinthePeople,sRepublicChina,t...mberoftheBeijingpharmaceuticaldelegation. ,, ...ConventionCenter,Chengdu ,, TheBeijingdelegat...
(Date:11/24/2009)...,, WARSAW,Ind.,Nov.24/PRNewswire-FirstCall/--...dayitwillbeparticipatinginthe21stAnnualPiperJaffra...,2009,at8:00a.m.EasternTime. ,, Alivewebcastoft...tionswebsiteat http://investor.zimmer.com .Thewebc...,, AbouttheCompany ,, Foundedin1927andhead...
(Date:11/24/2009)...,, SANDIEGO,Nov.24/PRNewswire-FirstCall/--Ore...armaceuticalcompanyfocusedonthetreatmentofobesity,...CommitteeoftheCompany,sBoardofDirectorsgrantedanin...stocktoPrestonKlassen,M.D.,itsnewlyappointedHeadof...tendedtobeanincentivestockoptiontotheextentpermitt...
Breaking Medicine Technology:Lotus Pharmaceuticals, Inc. to Exhibit at the 62nd PHARMCHINA 2Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) 2Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) 3Parascript Signature Verification Technology Used by Moscow Law Firm to Detect Signature Fraud in 24160 000 Debt Collection Case 8957 1Parascript Signature Verification Technology Used by Moscow Law Firm to Detect Signature Fraud in 24160 000 Debt Collection Case 8957 2Parascript Signature Verification Technology Used by Moscow Law Firm to Detect Signature Fraud in 24160 000 Debt Collection Case 8957 3Fruit fly steps in to fight human disease 12735 1Fruit fly steps in to fight human disease 12735 2HCPC Calls for Greater Healthcare Savings Through Improved Adherence to Prescription Drug Regimens 4630 1HCPC Calls for Greater Healthcare Savings Through Improved Adherence to Prescription Drug Regimens 4630 2HCPC Calls for Greater Healthcare Savings Through Improved Adherence to Prescription Drug Regimens 4630 3
...al Results Expected in Q3 2008, Conference Call t...tern Time, MOUNT...Inc. (Nasdaq: ALXA ) announced today that it has ... trial with AZ-004 (Staccato(R),loxapine). AZ-004 ... for,the treatment of acute agitation in patients ...
...Mass., June 9 Peptimmune, Inc., a privately,held ...sults from its,PI-2301 peptide copolymer program a... and at FOCIS 2008 in Boston, MA. The Company pres..., first-in-man study involving,healthy, male adult...ond-generation peptide copolymer PI-2301. This stu...
Other Medicine Technology:Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation 2Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation 3Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation 4Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation 5Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation 6Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation 7Peptimmune Presents Early Clinical Data at European Neurological Society and Federation of Clinical Immunology Societies Meetings 2Peptimmune Presents Early Clinical Data at European Neurological Society and Federation of Clinical Immunology Societies Meetings 3
(Date:11/24/2009)...onLaborLifeInsuranceCompany("UnionLaborLife")annou...on,slargestvisionbenefitsandservicescompany,toprov...ustfunds,unionemployersandtheirmembers. ,, VSPh...gcomprehensiveeyeexams,broadselectionsofopticalfra...is,"statedBruceSmith,NationalSales,VSP."Comprehens...
(Date:11/24/2009)...eripheral artery disease, researchers say , ...people aged 75 and older, the herbal supplement Gi... or death, a new study finds. , There is some e...prevent the leg-circulation problem known as perip...s nutrients called flavonoids, which are also foun...
(Date:11/24/2009)... between high- and low-volume centers, study found...- Do hospitals that conduct the most angioplasties...? Maybe not. , Prior research had suggested tha...-opening procedures, but a new study involving ove...tals performing more or less equally. , The stu...
(Date:11/24/2009)...y conducted by Children,s Hospital & Research Cent...erapeutic agents found naturally in soy that can p...most deadly form of cancer. Sphingadienes (SDs) ar...ch shows may be the key to fighting colon cancer. ...scientist and director of the Cancer Center at Chi...
(Date:11/24/2009)...--TheAmericanDentalAssociation(ADA)hassignedanagre...rsaspartofapilotprogramtoimprovetheoralhealthinund...hCoordinator(CDHC)isamemberofthedentalhealthteamwh...todentalcaretoimprovetheiroralhealth. ,, TheCDH...es--includingscreeningsandfluoridetreatments.Howev...
Breaking Medicine News(10 mins):Health News:Union Labor Life & VSP Vision Care Align to Offer Vision Insurance Products 2Health News:Ginkgo Won't Prevent Heart Attack, Stroke in Elderly 2Health News:Ginkgo Won't Prevent Heart Attack, Stroke in Elderly 3Health News:Angioplasty Outcomes May Vary Little Between Hospitals 2Health News:Angioplasty Outcomes May Vary Little Between Hospitals 3Health News:Children's Hospital Oakland scientists discover soy component may be key to fighting colon cancer 2Health News:ADA Launches Community Dental Health Coordinator Pilot Program at Temple University 2
...aster management , , ANAHEIM, Calif., May 4 , ..., May 17, 2009, WHERE: Anaheim Convention C... Anaheim, CA 92802, CONTACTS: Jessica Jois...nts The Art and Science of Dentistry, the, ...
...dical Insurance Strengthens Offerings to Colleges ...ore, MD. (Vocus) May 4, 2009 -- MEDEX Global Group...e acquisition of CMI Insurance, formerly a PSA com...t;We have worked hard on this deal and are very pl...
...ics Corporation (NYSE: HAE ) today reported reco...ighth consecutive quarter of double digit revenue ...et revenues of $598 million, up 16%; operating inc...ce, including continued double digit growth in ear...
...wing is a statement by Joon Yun, Director, Palo Al...from the fear of a swine flu pandemic, a panic tha.... , , Perhaps the original fear of swine flu ...ld happen again. , , Swine flu was first believe...
...e makers of Oust(R), announces that families looki... Johnson,s Oust(R) Surface Disinfectant & Air ...gainst influenza A virus. The US EPA has indicate...rks by chemically interacting with germs and virus...
...ygdala, a neural center for emotion, , , M... seem more likely to have an enlarged amygdala, a ...ions, University of North Carolina researchers rep...ification to a potential fundamental brain mechani...
Other Medicine News:Health News:Dentistry and Mass Disasters: A Dentist's Role as a First Responder During a Public Health Emergency 2Health News:Dentistry and Mass Disasters: A Dentist's Role as a First Responder During a Public Health Emergency 3Health News:MEDEX Acquires CMI Insurance 2Health News:MEDEX Acquires CMI Insurance 3Health News:Haemonetics Shares Success of Outstanding Fiscal 2009 Performance with Employees 2Health News:The Viral Spiral - How A Meme About the Virus May Be More Contagious Than the Virus Itself 2Health News:The Viral Spiral - How A Meme About the Virus May Be More Contagious Than the Virus Itself 3Health News:Oust(R) Surface Disinfectant & Air Sanitizer Effective Against H1N1 2Health News:Brain Anatomy Could Point to Autism 2Health News:Brain Anatomy Could Point to Autism 3
512 Lightweight Pneumatic Conserver
...e Conserver., ,Offers an average 5:1 increase in ...a standard cannula. , ,The combination of the OXY...mbulatory oxygen patients a superior alternative t...r warranty. , ,NOTE: Each model has passed th...
LOTUS™ Electronic Oxygen Conserver (with alarm)
Pfister Suture Adjustment Set For Astigmatism
Medicine Products: